Upcoming Projects (D4S.F)
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (D4S.F)
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (D4S.F)
MolecularMD Has Obtained CE Marking of a Diagnostic Assay Developed for a Daiichi Sankyo Phase II Clinical Trial
Tickers: MOLECULARMD, D4S.F
Occurred on: Apr 25, 2016
Strategic Initiatives (D4S.F)
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Tickers: AMGN, D4S.F
Announcement Date: Jul 13, 2016